← Back to All US Stocks

NHPBP Stock Analysis 2026 - National Healthcare Properties, Inc. AI Rating

NHPBP Nasdaq Real Estate Investment Trusts MD CIK: 0001561032
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2025-12-31
STRONG SELL
87% Conf
Pending
Analysis scheduled

📊 NHPBP Key Takeaways

Revenue: $342.3M
Net Margin: -20.8%
Free Cash Flow: $-9.8M
Current Ratio: N/A
Debt/Equity: 1.74x
EPS: $-2.51
AI Rating: STRONG SELL with 87% confidence

Is NHPBP a Good Investment? Thesis Analysis

Claude

National Healthcare Properties exhibits severe financial distress with negative net income (-$71.1M), declining revenue (-3.3% YoY), and dangerously high leverage (1.74x debt-to-equity) coupled with zero interest coverage ratio, indicating inability to service its $1.0B debt burden. Negative free cash flow of -$9.8M demonstrates the company is consuming capital rather than generating it, creating acute refinancing and solvency risk.

Why Buy NHPBP? Key Strengths

Claude
  • + Reasonable gross margin of 36.0% on healthcare property operations
  • + Substantial asset base of $1.7B reflecting significant real estate holdings appropriate for REIT structure
  • + Positive operating cash flow of $7.0M provides minimal liquidity cushion

NHPBP Investment Risks to Consider

Claude
  • ! Interest coverage ratio of 0.0x indicates operating income completely insufficient to service debt obligations
  • ! Negative free cash flow of -$9.8M means company is burning capital and unable to self-fund capital expenditures
  • ! Combined revenue decline (-3.3% YoY), negative profitability (-20.8% net margin), and high leverage (1.74x D/E) create acute solvency concerns

Key Metrics to Watch

Claude
  • * Quarterly free cash flow trends and path to positive FCF generation
  • * Revenue stabilization and occupancy rate metrics across property portfolio
  • * Debt covenant compliance and refinancing ability given zero interest coverage

NHPBP Financial Metrics

Revenue
$342.3M
Net Income
$-71.1M
EPS (Diluted)
$-2.51
Free Cash Flow
$-9.8M
Total Assets
$1.7B
Cash Position
$57.6M

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

NHPBP Profitability Ratios

Gross Margin 36.0%
Operating Margin 1.0%
Net Margin -20.8%
ROE -11.8%
ROA -4.2%
FCF Margin -2.9%

NHPBP vs Default Sector

How National Healthcare Properties, Inc. compares to Default sector averages

Net Margin
NHPBP -20.8%
vs
Sector Avg 12.0%
NHPBP Sector
ROE
NHPBP -11.8%
vs
Sector Avg 15.0%
NHPBP Sector
Current Ratio
NHPBP 0.0x
vs
Sector Avg 1.8x
NHPBP Sector
Debt/Equity
NHPBP 1.7x
vs
Sector Avg 0.7x
NHPBP Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is NHPBP Overvalued or Undervalued?

Based on fundamental analysis, National Healthcare Properties, Inc. shows some fundamental concerns relative to the Default sector in 2026.

Return on Equity
-11.8%
Sector avg: 15%
Net Profit Margin
-20.8%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
1.74x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

NHPBP Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
1.74x
Debt/Assets
64.7%
Interest Coverage
0.05x
Long-term Debt
$1.0B

NHPBP 5-Year Financial Trend & Growth Analysis

NHPBP 5-year financial data: Year 2021: Revenue $381.6M, Net Income -$88.3M, EPS $-0.88. Year 2022: Revenue $381.6M, Net Income -$75.5M, EPS $-0.74. Year 2023: Revenue $345.9M, Net Income -$85.4M, EPS $-0.82. Year 2024: Revenue $353.8M, Net Income -$79.6M, EPS $-3.30. Year 2025: Revenue $353.8M, Net Income -$72.4M, EPS $-3.04.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: National Healthcare Properties, Inc.'s revenue has remained relatively flat over the 5-year period, with a 7% decline. The most recent EPS of $-3.04 indicates the company is currently unprofitable.

NHPBP Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-2.9%
Free cash flow / Revenue

NHPBP Quarterly Performance

Quarterly financial performance data for National Healthcare Properties, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $86.0M -$12.5M $-0.56
Q2 2025 $85.3M -$20.8M $-0.85
Q1 2025 $86.4M -$1.5M $-0.18
Q3 2024 $85.7M -$16.1M $-0.69
Q2 2024 $86.1M -$17.3M $-0.18
Q1 2024 $87.4M -$14.1M $-0.15
Q3 2023 $83.5M -$16.1M $-0.18
Q2 2023 $83.8M -$17.3M $-0.19

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

NHPBP Capital Allocation

Operating Cash Flow
$7.0M
Cash generated from operations
Capital Expenditures
$16.7M
Investment in assets
Dividends
None
No dividend program

NHPBP SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for National Healthcare Properties, Inc. (CIK: 0001561032)

📋 Recent SEC Filings

Date Form Document Action
Mar 31, 2026 DEF 14A ny20060345x1_def14a.htm View →
Feb 20, 2026 8-K hct-20260220.htm View →
Feb 20, 2026 10-K hct-20251231.htm View →
Jan 12, 2026 8-K hct-20260109.htm View →
Dec 11, 2025 8-K hct-20251211.htm View →

Frequently Asked Questions about NHPBP

What is the AI rating for NHPBP?

National Healthcare Properties, Inc. (NHPBP) has an AI rating of STRONG SELL with 87% confidence, based on fundamental analysis of SEC EDGAR filings.

What are NHPBP's key strengths?

Claude: Reasonable gross margin of 36.0% on healthcare property operations. Substantial asset base of $1.7B reflecting significant real estate holdings appropriate for REIT structure.

What are the risks of investing in NHPBP?

Claude: Interest coverage ratio of 0.0x indicates operating income completely insufficient to service debt obligations. Negative free cash flow of -$9.8M means company is burning capital and unable to self-fund capital expenditures.

What is NHPBP's revenue and growth?

National Healthcare Properties, Inc. reported revenue of $342.3M.

Does NHPBP pay dividends?

National Healthcare Properties, Inc. does not currently pay dividends.

Where can I find NHPBP SEC filings?

Official SEC filings for National Healthcare Properties, Inc. (CIK: 0001561032) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is NHPBP's EPS?

National Healthcare Properties, Inc. has a diluted EPS of $-2.51.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is NHPBP a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, National Healthcare Properties, Inc. has a STRONG SELL rating with 87% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is NHPBP stock overvalued or undervalued?

Valuation metrics for NHPBP: ROE of -11.8% (sector avg: 15%), net margin of -20.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy NHPBP stock in 2026?

Our dual AI analysis gives National Healthcare Properties, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is NHPBP's free cash flow?

National Healthcare Properties, Inc.'s operating cash flow is $7.0M, with capital expenditures of $16.7M. FCF margin is -2.9%.

How does NHPBP compare to other Default stocks?

Vs Default sector averages: Net margin -20.8% (avg: 12%), ROE -11.8% (avg: 15%), current ratio N/A (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2025-12-31 | Powered by Claude AI